APOTHEEK BRECX
The computed 12-month bankruptcy probability of APOTHEEK BRECX is 0.5% (very low). The 2025 annual accounts show equity of €317k and a net result of €137k. The company has been active since 1974 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €317k |
| Net result | €137k |
| Staff (FTE) | 0.8 |
| Active | 52 yrs |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €161k |
| Net profit | €137k |
| Cash flow | €142k |
| Staff costs | €76k |
| Income taxes | €18k |
| Dividends | €0 |
| Total assets | €540k |
| Equity | €317k |
| Debt | €223k |
| of which ≤ 1y | €223k |
| of which > 1y | - |
| Working capital | €303k |
| Employees (FTE) | 0.8 |
| 2025 | |
|---|---|
| Current ratio | 2.36 |
| Quick ratio | 1.39 |
| Working capital ratio | 56.1% |
| Solvency | 58.6% |
| Debt / equity | 0.71 |
| Long-term debt ratio | - |
| Interest coverage | 49.24 |
| Gross margin | - |
| Net margin | - |
| ROA | 25.4% |
| ROE | 43.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (23 line items)
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €540k |
| Fixed assets | 21/28 | €14k |
| Tangible fixed assets | 22/27 | €14k |
| Current assets | 29/58 | €526k |
| Stocks & contracts in progress | 3 | €215k |
| Amounts receivable within one year | 40/41 | €136k |
| Cash & bank | 54/58 | €167k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €540k |
| Equity | 10/15 | €317k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €84k |
| Accumulated profits (losses) | 14 | €214k |
| Amounts payable | 17/49 | €223k |
| Amounts payable within one year | 42/48 | €223k |
| Trade debts payable within one year | 44 | €61k |
| Income statement | ||
| Gross operating margin | 9900 | €237k |
| Operating result | 9901 | €157k |
| Financial income | 75 | €2k |
| Financial charges | 65 | €3k |
| Result before taxes | 9903 | €155k |
| Income taxes | 67/77 | €18k |
| Net result for the period | 9904 | €137k |
| Result to be appropriated | 9905 | €137k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 09-05-1974 |
| Status | Active |
| Postal code | 2480 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13006C0001/02C003 | Flanders | 768 m² | 1 · 152 m² | 6.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
18-06-2024 Articles of association amended, alignment with the new Companies Code and full restatement of the articles
Technical details
{
"notary": {
"name": "Jan VAN ERMENGEM",
"firm_city": null,
"firm_name": null,
"office_city": "Meerhout",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-06-18",
"filing_date": "2024-06-14",
"act_kind_objet": "WIJZIGING RECHTSVORM, ONTSLAGEN, BENOEMINGEN"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-06-04",
"unanimous": true
},
"statute_change": {
"kinds": [
"wvv_adaptation",
"full_restatement"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0414.221.870",
"name_full_after": "APOTHEEK BRECX",
"legal_form_after": "B.V.",
"name_full_before": "APOTHEEK BRECX",
"current_zetel_raw": "Meistraat 128, 2480 Dessel",
"legal_form_before": "B.V."
},
"special_mandates": [
{
"holder_kbo": "0662.975.105",
"holder_name": "Van den Bempt \u2013 Michel \u0026 Partners",
"scope_categories": [
"kbo",
"ubo",
"estox",
"publication",
"tax"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Besluit de vergadering om de statuten aan te passen aan de bepalingen van het Wetboek van Vennootschappen en Verenigingen en de rechtsvorm van de besloten vennootschap te behouden.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "39, \u00A71"
},
{
"summary": "Stelt de vergadering vast dat het werkelijk gestort kapitaal en de wettelijke reserve van rechtswege werden omgezet in een statutair onbeschikbare eigen vermogensrekening en dat het nog niet gestort deel van het kapitaal werd omgezet in een eigen vermogensrekening \u201Cniet-opgevraagde inbrengen\u201D.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "39, \u00A72"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "J. Van Ermengem",
"org_rep_person_name": null
},
"co_filed_documents": [
"expeditie van de akte",
"geco\u00F6rdineerde statuten"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": "In het geval dat wordt beslist en overgegaan tot de uitkering van een liquidatiereserve, zal deze uitkering beschouwd worden als vrucht en bijgevolg integraal toekomen aan de vruchtgebruiker zo het eigendomsrecht is opgesplitst in blote eigendom en vruchtgebruik.",
"voorkeurrecht_rules_changed": false,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": "De vennootschap heeft tot voorwerp de uitbating van apotheken, de handel in en fabricatie van scheikundige, farmaceutische en parafarmaceutische producten, het ondernemen van industri\u00EBle en klinische ontledingen, de handel in fytopharmaceutische producten, parfumerie, bandagisterie en optiek, en het verrichten van alle commerci\u00EBle, industri\u00EBle, financi\u00EBle roerende en onroerende handelingen die rechtstreeks of onrechtstreeks verband houden met haar voorwerp.",
"capital_structure_change": {
"operations": [
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": null,
"shares_before": null,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": []
},
"coordinated_text_lineage": null
}| Legal nameNL | APOTHEEK BRECX |